Dominique Agbor‐Tarh

Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01)

Evandro de Azambuja, Marion Procter, Dirk J. van Veldhuisen et al. · Journal of Clinical Oncology · 2014 · 230 citations · Full text

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

Amir Sonnenblick, Dominique Agbor‐Tarh, Ian Bradbury et al. · Journal of Clinical Oncology · 2017 · 164 citations · Full text

Diabetes Management, Breast Oncology, Medicine +13

High HER2 Expression Correlates with Response to the Combination of Lapatinib and Trastuzumab

Maurizio Scaltriti, Paolo Nucíforo, Ian Bradbury et al. · Clinical Cancer Research · 2014 · 102 citations · Full text

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial

Hatem A. Azim, Dominique Agbor‐Tarh, Ian Bradbury et al. · Journal of Clinical Oncology · 2013 · 63 citations · Full text

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

Carmen Criscitiello, Hatem A. Azim, Dominique Agbor‐Tarh et al. · Annals of Oncology · 2013 · 48 citations

Surgical Oncology, Breast Oncology, Neoadjuvant Therapy +10